Skip to content

Treatment of Keloids and Hypertrophic Scars with a Long-pulsed Nd:YAG Laser in non-contact mode

Treatment of Keloids and Hypertrophic Scars with a Long-pulsed Nd:YAG Laser in non-contact mode - Treatment of Keloids and Hypertrophic Scars with a Long-pulsed Nd:YAG Laser in non-contact mode

Status
Active, not recruiting
Phases
Phase 1
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000001208
Enrollment
20
Registered
2008-12-31
Start date
2006-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

keloids and hypertrophic scars

Interventions

None listed

Sponsors

Plastic, Reconstructive and Aesthetic Surgery, Nippon Medical School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: The subjects were 22 Japanese patients (four males and 18 females) with a mean age of 34.95 years. Of these patients, 16 had keloids and six had hypertrophic scars. We defined keloids as scars that extended beyond the confines of the original wound.

Exclusion criteria

Exclusion criteria: none received any other treatment

Design outcomes

Primary

MeasureTime frame
The patients were treated every 3 to 4 weeks with the long-pulsed 1064-nm Nd:YAG laser (GenesisTM, Cutera Inc., Brisbane, CA, USA), which was applied in non-contact mode with a spot size that was 5 mm in diameter, an energy density of 14 J/cm2, an exposure time per pulse of 0.3 msec, and a repetition rate of 10 Hz. 500 to 1000 pulses per cm2. The frequency of irradiation ranged from 5 to 49 exposures and averaged 14.05 exposures. The response of the scars to the laser treatment was assessed by measuring the following five parameters: color, degree of hypertrophy, hardness of hypertrophy, itching, spontaneous pain, and tenderness. The assessments were performed by two experienced physicians (S.K. and R.O.) before the treatments started and after they were completed. Scoring was based on a 4-point scale ranging from 0 to 3 (0 = absent; 1 = mild; 2 = moderate; 3 = severe. In other words, the maximum possible score for a patient was 15 points.

Countries

Japan

Contacts

Public ContactSatoshi Akaishi

Nippon Medical School Hospital Plastic, Reconstructive and Aesthetic Surgery

redstoneprs@gmail.com03-3822-2131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026